Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zishen Yutong pill is a Traditional Chinese Medicine (TCM) hospital preparation developed by Sun Yat-sen Memorial Hospital of Sun Yat-sen University. It is specifically formulated for the treatment of threatened abortion and the prevention of recurrent miscarriage. The medicine is designed based on TCM principles to nourish the kidney, strengthen the spleen, and stabilize the fetus. It is typically used as an adjuvant therapy alongside conventional treatments such as progesterone to improve clinical outcomes in pregnant women experiencing early pregnancy bleeding or other signs of threatened miscarriage. As a hospital-made preparation, its use is primarily concentrated within the originating institution and its affiliated clinical network.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zishen Yutong pill.